<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[SAFETY CARE]]></title><description><![CDATA[Solutions en isolateurs et salles blanches, installation, maintenance et conformité pour environnements pharmaceutiques et médicaux.]]></description><link>https://www.safety-care.ma/blog</link><generator>RSS for Node</generator><lastBuildDate>Fri, 17 Apr 2026 10:49:26 GMT</lastBuildDate><atom:link href="https://www.safety-care.ma/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Healthcare Risk Mitigation in Cytotoxic Compounding Units: Why Pharmaceutical Isolators Represent a Strategic Standard of Care]]></title><description><![CDATA[Cytotoxic drug compounding environments have a lot of hazards. These hazards are related to microbes, chemicals and the people who work with these drugs. Traditional front biological safety cabinets and laminar airflow hoods are used a lot but they can still expose healthcare institutions to contamination risks, personnel exposure and hidden costs. This paper looks at what happens when we switch from hoods to closed-system pharmaceutical isolators. We consider the operational and economic...]]></description><link>https://www.safety-care.ma/post/healthcare-risk-mitigation-in-cytotoxic-compounding-units-why-pharmaceutical-isolators-represent-a</link><guid isPermaLink="false">69c4d613653657f03d5eccde</guid><pubDate>Wed, 18 Feb 2026 00:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5257b5_526e2d93962a4f67ba8055a902fb7e37~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>contact@safety-care.ma</dc:creator></item></channel></rss>